Clinical Trials Directory

Trials / Unknown

UnknownNCT04443205

Relevance of Ultrasound Screening for Foetal Macrosomia

Relevance of Ultrasound Screening for Foetal Macrosomia and Description of Its Management in Champagne-Ardenne

Status
Unknown
Phase
Study type
Observational
Enrollment
3,000 (estimated)
Sponsor
CHU de Reims · Academic / Other
Sex
Female
Age
Healthy volunteers
Not accepted

Summary

Management of fetal macrosomia is based on a suspicion of macrosomia (no certainty before birth). This management is an artificial induction of labour for an earlier delivery and therefore a lower fetal weight gain. Several studies have already shown that ultrasound performed during the third trimester of pregnancy was not a perfect tool for this screening.

Detailed description

The aim of the study is to describe management of women whose child is macrosomal but has not been screened g using ultrasound during the third trimester of pregnancy.

Conditions

Interventions

TypeNameDescription
OTHERData recordData record

Timeline

Start date
2020-06-01
Primary completion
2021-09-01
Completion
2021-12-01
First posted
2020-06-23
Last updated
2020-06-23

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04443205. Inclusion in this directory is not an endorsement.

Relevance of Ultrasound Screening for Foetal Macrosomia (NCT04443205) · Clinical Trials Directory